Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  64 results for ""BLOOD coagulation factor VIII antibodies""

Your Filters

Subject : fviii inhibitors
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Plasma‐derived FVIII/VWF complex shows higher protection against inhibitors than isolated FVIII after infusion in haemophilic patients: A translational study.

Subjects: *BLOOD coagulation factor VIII antibodies; *VON Willebrand factor; *DESMOPRESSINBETHESDA (Md.)

  • Source: Haemophilia. Sep2022, Vol. 28 Issue 5, p737-744. 8p. 1 Chart, 3 Graphs.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

BAFF rs9514828 gene polymorphism and the risk of the development of inhibitors in children with severe haemophilia A.

Subjects: *GENETIC polymorphisms; *BLOOD coagulation factor VIII antibodies; *CHILD development

  • Source: Haemophilia. May2022, Vol. 28 Issue 3, p472-479. 8p. 5 Charts, 2 Graphs.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Neutralizing capacity of inhibitors on FVIII is lower for natural FVIII/ VWF complex than for isolated FVIII: in vitro comparative study in eleven different therapeutic FVIII concentrates.

Subjects: *BLOOD coagulation factor VIII antibodies; *VON Willebrand factor; *COMPARATIVE studies

  • Source: Haemophilia. Jul2016, Vol. 22 Issue 4, pe341-e344. 4p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A—Final efficacy and safety results from the NuProtect study.

Subjects: *HEMOPHILIACS; *BLOOD coagulation factor VIII antibodies; *IMMUNE response

  • Source: European Journal of Haematology. Oct2023, Vol. 111 Issue 4, p544-552. 9p.

Record details

Read More Add to Saved list
×
Academic Journal

Inhibitors—Recent insights.

Subjects: *BLOOD coagulation factor VIII antibodies; *GENE therapy; *IMMUNOLOGICAL tolerance

  • Source: Haemophilia. Feb2021 Supplemen tS3, Vol. 27, p28-36. 9p. 1 Chart, 1 Graph.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Short term efficacy of recombinant porcine factor VIII in patients with factor VIII inhibitors.

Subjects: *BLOOD coagulation factor VIII antibodies; *PARTIAL thromboplastin timeBETHESDA (Md.)

  • Source: Haemophilia. Jul2020, Vol. 26 Issue 4, p601-606. 6p. 2 Charts, 2 Graphs.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Frequency of inhibitor development in severe haemophilia A children treated with cryoprecipitate and low-dose immune tolerance induction.

Subjects: *BLOOD coagulation factor VIII antibodies; *HEMOPHILIA

  • Source: Haemophilia. Nov2000, Vol. 6 Issue 6, p635-638. 4p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery.

Subjects: *EMICIZUMAB; *BLOOD coagulation factor VIII antibodies; *HEMOPHILIA

  • Source: Haemophilia. Jul2021, Vol. 27 Issue 4, p519-530. 12p. 2 Charts.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The Development of FVIII Inhibitors in Relation to IL10 Gene Polymorphism in Hemophilia A Egyptian Pediatric Patients.

Subjects: *BLOOD coagulation factor VIII antibodies; *GENETIC polymorphisms; *BLOOD coagulation disorders

  • Source: Fetal & Pediatric Pathology. Jun2017, Vol. 36 Issue 3, p184-189. 6p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Porcine recombinant factor VIII (Obizur; OBI-1; BAX801): product characteristics and preclinical profile.

Subjects: *BLOOD coagulation factor VIII antibodies; *MEDICAL sciences; *HEMOPHILIA treatment

  • Source: Haemophilia. Mar2016, Vol. 22 Issue 2, p308-317. 10p. 1 Color Photograph, 1 Diagram, 4 Charts, 2 Graphs.

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  64 results for ""BLOOD coagulation factor VIII antibodies""